Altaris Acquires Simulations Plus
June 17, 2026
Altaris acquired Simulations Plus in an all-cash transaction valued at approximately $375 million, with shareholders receiving $18.50 per share. The acquisition was completed on October 6, 2026, and Simulations Plus is being combined with Altaris portfolio company Chemical Computing Group to broaden the combined drug discovery, modeling, and simulation software platform.
- Buyers
- Altaris, LLC
- Targets
- Simulations Plus, Inc.
- Platforms
- Chemical Computing Group
- Industry
- Software
- Location
- North Carolina, United States
- Transaction Type
- Addon
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.